FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2575140179> ?p ?o ?g. }

• W2575140179 endingPage "3658" @default.
• W2575140179 startingPage "3658" @default.
• W2575140179 abstract "Abstract Introduction The ETV6-RUNX1 fusion gene,the most common subtype of childhood pB-ALL, is acquired in utero, producing a persistent and hidden preleukemic clone. However, the underlying mechanism explaining how the preleukemic clone evolves to pB-ALL remains to be identified. The lack of genetically engineered human-like ETV6-RUNX1 pB-ALL models has hampered our understanding of the pathogenesis of this disease. Methods We have used a novel experimental approach to generate a murine strain that mimics the human ETV6-RUNX1 pB-ALL. We expressed ETV6-RUNX1 specifically in hematopoietic stem cells (HSC) of C57BL/6 x CBA mice by placing ETV6-RUNX1 under the control of the Sca1 promoter. Two founder mice were obtained for the Sca1-ETV6-RUNX1 transgene, which had normal gestation, were viable and developed normally. Sca1-ETV6-RUNX1 transgenic mice were characterized with respect to clinical, immunephenotypic and genetic characteristics. For the detection of shared secondary genomic alterations we analyzed three murine Sca1-ETV6-RUNX1 and 11 ETV6-RUNX1 positive human pB-ALL and corresponding germline by whole-exome (WES) and whole-genome sequencing using a HiSeq 2500 (Illumina) platform. Results In our transgenic murine model Sca1-ETV6-RUNX1 transgene expression was detected in HSCs, while there was no detectable expression in pro B cells or later stages of B-cell development, which mimics human ETV6-RUNX1 preleukemic biology. Sca1-ETV6-RUNX1 mice developed exclusively pB-ALL at a low penetrance (7.5%; 3 out of 40) with a CD19+ B220+ IgM- cell surface phenotype. Overall survival was not significantly reduced compared to wild-type mice (P value = 0.7901). pB-ALL in Sca1-ETV6-RUNX1 mice manifested with splenomegaly, disruption of splenic architecture, and appearance of blast cells in the peripheral blood (PB). All leukemic cells displayed clonal immature BCR rearrangement. Tumor pro B cells grew independent of IL-7 and were able to propagate the disease when transplanted into sub-lethally irradiated syngeneic recipient mice. Whole-exome sequencing of murine pB-ALL revealed in one mouse a deletion of three amino acids in the B-cell differentiation factor EBF1, which is well known in the context of human ETV6-RUNX1 leukemia. Additionally we found mutations in genesimplicated in histone modification, i.e. in KDM5C causing a premature translation stop. We compared the genomic alterations detected in the mouse model to published genomic data of pediatric ETV6 -RUNX1 pB-ALL and identified multiple copy number variations, which are shared between the murine and human ETV6 -RUNX1 pB-ALL. Among them were copy number gains and losses including i.e. the tumorsuppressor locus CDKN2A/B with a well-known role in human and mouse pB-ALL. A high proportion of genes implicated in histone modification was also mutated in published data of human ETV6-RUNX1 positive pB-ALL. We validated this novel finding of recurrent alterations of histone modifying genes in both the murine model and the human disease using an independent human ETV6-RUNX1 cohort of 11 patients. In this cohort were able to reproduce this finding. Similar to the murine model, we also detected a missense mutation in the methyltransferase KDM5C in one patient of our cohort of ETV6-RUNX1 positive patients. Conclusion In summary, we have characterized a new Sca1-ETV6-RUNX1 mouse model and this is, to our knowledge the first model, which represents a phenocopy of the human pB-ALL. Sca1-ETV6-RUNX1 mice develop exclusively pB-ALL at a very low penetrance as it is the case in human ETV6-RUNX1 positive pB-ALL. The acquisition of secondary mutations in pB-ALL with a high proportion in histone modifying genes confers the second hit for the conversion of a preleukemic clone into the clinically overt ETV6-RUNX1 positive pB-ALL disease. These findings are important for encouraging novel interventions that might help to prevent or treat ETV6-RUNX1 positive childhood leukemias. Disclosures No relevant conflicts of interest to declare." @default.
• W2575140179 created "2017-01-26" @default.
• W2575140179 creator A5002071945 @default.
• W2575140179 creator A5017625141 @default.
• W2575140179 creator A5021529576 @default.
• W2575140179 creator A5024525126 @default.
• W2575140179 creator A5027098748 @default.
• W2575140179 creator A5027206365 @default.
• W2575140179 creator A5029982305 @default.
• W2575140179 creator A5030213661 @default.
• W2575140179 creator A5032050812 @default.
• W2575140179 creator A5033002324 @default.
• W2575140179 creator A5036772713 @default.
• W2575140179 creator A5038729085 @default.
• W2575140179 creator A5039439291 @default.
• W2575140179 creator A5040479140 @default.
• W2575140179 creator A5040964471 @default.
• W2575140179 creator A5046439201 @default.
• W2575140179 creator A5056992056 @default.
• W2575140179 creator A5062364819 @default.
• W2575140179 creator A5062623358 @default.
• W2575140179 creator A5068819185 @default.
• W2575140179 creator A5077566992 @default.
• W2575140179 creator A5083037807 @default.
• W2575140179 creator A5086110717 @default.
• W2575140179 creator A5086294439 @default.
• W2575140179 creator A5087088497 @default.
• W2575140179 creator A5088484003 @default.
• W2575140179 creator A5088869451 @default.
• W2575140179 creator A5088888518 @default.
• W2575140179 date "2015-12-03" @default.
• W2575140179 modified "2023-10-11" @default.
• W2575140179 title "A New ETV6-RUNX1 In Vivo Model Produces a Phenocopy of the Human Pb-ALL" @default.
• W2575140179 doi "https://doi.org/10.1182/blood.v126.23.3658.3658" @default.
• W2575140179 hasPublicationYear "2015" @default.
• W2575140179 type Work @default.
• W2575140179 sameAs 2575140179 @default.
• W2575140179 citedByCount "0" @default.
• W2575140179 crossrefType "journal-article" @default.
• W2575140179 hasAuthorship W2575140179A5002071945 @default.
• W2575140179 hasAuthorship W2575140179A5017625141 @default.
• W2575140179 hasAuthorship W2575140179A5021529576 @default.
• W2575140179 hasAuthorship W2575140179A5024525126 @default.
• W2575140179 hasAuthorship W2575140179A5027098748 @default.
• W2575140179 hasAuthorship W2575140179A5027206365 @default.
• W2575140179 hasAuthorship W2575140179A5029982305 @default.
• W2575140179 hasAuthorship W2575140179A5030213661 @default.
• W2575140179 hasAuthorship W2575140179A5032050812 @default.
• W2575140179 hasAuthorship W2575140179A5033002324 @default.
• W2575140179 hasAuthorship W2575140179A5036772713 @default.
• W2575140179 hasAuthorship W2575140179A5038729085 @default.
• W2575140179 hasAuthorship W2575140179A5039439291 @default.
• W2575140179 hasAuthorship W2575140179A5040479140 @default.
• W2575140179 hasAuthorship W2575140179A5040964471 @default.
• W2575140179 hasAuthorship W2575140179A5046439201 @default.
• W2575140179 hasAuthorship W2575140179A5056992056 @default.
• W2575140179 hasAuthorship W2575140179A5062364819 @default.
• W2575140179 hasAuthorship W2575140179A5062623358 @default.
• W2575140179 hasAuthorship W2575140179A5068819185 @default.
• W2575140179 hasAuthorship W2575140179A5077566992 @default.
• W2575140179 hasAuthorship W2575140179A5083037807 @default.
• W2575140179 hasAuthorship W2575140179A5086110717 @default.
• W2575140179 hasAuthorship W2575140179A5086294439 @default.
• W2575140179 hasAuthorship W2575140179A5087088497 @default.
• W2575140179 hasAuthorship W2575140179A5088484003 @default.
• W2575140179 hasAuthorship W2575140179A5088869451 @default.
• W2575140179 hasAuthorship W2575140179A5088888518 @default.
• W2575140179 hasConcept C104317684 @default.
• W2575140179 hasConcept C12387725 @default.
• W2575140179 hasConcept C126322002 @default.
• W2575140179 hasConcept C127716648 @default.
• W2575140179 hasConcept C207001950 @default.
• W2575140179 hasConcept C54355233 @default.
• W2575140179 hasConcept C71924100 @default.
• W2575140179 hasConcept C86803240 @default.
• W2575140179 hasConceptScore W2575140179C104317684 @default.
• W2575140179 hasConceptScore W2575140179C12387725 @default.
• W2575140179 hasConceptScore W2575140179C126322002 @default.
• W2575140179 hasConceptScore W2575140179C127716648 @default.
• W2575140179 hasConceptScore W2575140179C207001950 @default.
• W2575140179 hasConceptScore W2575140179C54355233 @default.
• W2575140179 hasConceptScore W2575140179C71924100 @default.
• W2575140179 hasConceptScore W2575140179C86803240 @default.
• W2575140179 hasIssue "23" @default.
• W2575140179 hasLocation W25751401791 @default.
• W2575140179 hasOpenAccess W2575140179 @default.
• W2575140179 hasPrimaryLocation W25751401791 @default.
• W2575140179 hasVolume "126" @default.
• W2575140179 isParatext "false" @default.
• W2575140179 isRetracted "false" @default.
• W2575140179 magId "2575140179" @default.
• W2575140179 workType "article" @default.